bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) Transcript
My name is Turner Kufe, and I'm a junior biotech analyst here at JPMorgan. It's my pleasure to introduce Blue's CEO, Nick Leschly. Especially after this morning's news, I'm sure we'll make this a very informative session. So following the presentation, we'll move into Q&A. And remember, everyone is encouraged to ask questions. So feel free to hit that blue button, no pun intended there, or feel free to e-mail me or our IBM, and I confining your questions as best as possible.
So with that, Nick, why don't I hand it over to you for the presentation.
Thank you, Turner. I appreciate it, and thank you very much, JPMorgan, for giving us yet again, this opportunity to talk about Blue at this steam conference. There's obviously a lot going on in the world. I'd like to acknowledge extremely troubling events of this past week. And it's very clear that all of us as a global community, have a lot of work to do, and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
